Brian Pavey is a Nephrology physician. OpenAlex indexes 7 publications with 232 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
737 E Crawford St
Salina, KS 674015103
Telephone
785-827-7261Provider last certified this registry record 27 Apr 2021.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20257 payments
- Stryker CorporationProgram year20251 payment
- PFIZER INC.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51%Loop diuretic10.5%Furosemide82%Bumetanide18%Part D<11 patientsAngiotensin receptor blocker (ARB)7.9%Losartan Potassium76%Valsartan14%Losartan-Hydrochlorothiazide10%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
15.4%Proton pump inhibitor3.4%Omeprazole58%Pantoprazole Sodium42%Part D<11 patientsPotassium supplement3.2%Potassium Chloride100%Part D≥16 patients+ 6 more classes in this area
Nervous system
9.6%SSRI3%Escitalopram Oxalate49%Sertraline Hcl32%Trazodone Hcl19%Part D<11 patientsOpioid Agonist1.8%Tramadol Hcl51%Oxycodone-Acetaminophen49%Part D<11 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dysglycemia Predicts Cardiovascular and Kidney Disease in the Kidney Early Evaluation Program
Journal of Clinical Hypertension
2009 - 207: Prevalent Components of Cardiometabolic Syndrome and Cardiovascular Disease from the Kidney Early Evaluation Program (KEEP)
American Journal of Kidney Diseases
2008 - Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection
Therapeutic Advances in Cardiovascular Disease
2007 - Obesity and Insulin Resistance As Risk Factors for Chronic Kidney Disease
Journal of the CardioMetabolic Syndrome
2006 - Rates of continuous ambulatory peritoneal dialysis-associated peritonitis at the University of Missouri.
PubMed
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”